Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer
The primary objective was to confirm the effect of tasquinimod in delaying disease progression or death as compared with placebo in chemo-naïve patients with metastatic castrate-resistant prostate cancer (mCRPC). Secondary objectives included further evaluation of the safety profile of tasquinimod, comparison of clinical benefits (such as overall survival and symptoms) of tasquinimod with placebo, to evaluate the quality of life impact and to determine the pharmacokinetics of tasquinimod.
Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer
The primary objective was to confirm the effect of tasquinimod in delaying disease progression or death as compared with placebo in chemo-naïve patients with metastatic castrate-resistant prostate cancer (mCRPC). Secondary objectives included further evaluation of the safety profile of tasquinimod, comparison of clinical benefits (such as overall survival and symptoms) of tasquinimod with placebo, to evaluate the quality of life impact and to determine the pharmacokinetics of tasquinimod.
En rapport Clinical Trials
![Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
![Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
![Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
![Dysport® Pediatric Lower Limb Spasticity Follow-on Study Dysport® Pediatric Lower Limb Spasticity Follow-on Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
![Dysport® Adult Lower Limb Spasticity Follow-on Study Dysport® Adult Lower Limb Spasticity Follow-on Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Dysport® Adult Lower Limb Spasticity Follow-on Study
![Dysport® Pediatric Lower Limb Spasticity Study Dysport® Pediatric Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Dysport® Pediatric Lower Limb Spasticity Study
![Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
![Dysport® Adult Lower Limb Spasticity Study Dysport® Adult Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Dysport® Adult Lower Limb Spasticity Study
![Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
![Dysport in the Treatment of Glabellar Lines in Chinese Subjects Dysport in the Treatment of Glabellar Lines in Chinese Subjects](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)